Page last updated: 2024-10-28

hycanthone and Leukemia L 1210

hycanthone has been researched along with Leukemia L 1210 in 2 studies

Hycanthone: Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.
hycanthone : A thioxanthen-9-one compound having a hydroxymethyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. It was formerly used (particularly as the monomethanesulfonic acid salt) as a schistosomicide for individual or mass treatement of infection with Schistosoma haematobium and S. mansoni, but due to its toxicity and concern about possible carcinogenicity, it has been replaced by other drugs such as praziquantel.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lelieveld, P1
Pommerenke, EW1
Osswald, H1
Hahn, EW1
Volm, M1

Other Studies

2 other studies available for hycanthone and Leukemia L 1210

ArticleYear
Cell killing effectiveness of hycanthone.
    European journal of cancer, 1977, Volume: 13, Issue:8

    Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Hycanthone; Leuk

1977
Activity of various amphiphilic agents in reversing multidrug resistance of L 1210 cells.
    Cancer letters, 1990, Nov-19, Volume: 55, Issue:1

    Topics: Animals; Drug Resistance; Ethylamines; Hycanthone; Leukemia L1210; Phenotype; Piperidines; Quinidine

1990